| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Business Officer | COO &Cbo
1 company
Nash Huw M. is a Chief Business Officer at Stoke Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 22 sells.
Estimated insider holdings value: $1K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2021 | STOK Stoke Therapeutics, Inc. | COO &Cbo | Sale+OE | 5,700 | $33.33 | $189,986.70 | -100% | -25.2% | -59.6% | |
| Jun 1, 2021 | STOK Stoke Therapeutics, Inc. | COO &Cbo | Sale+OE | 575 | $39.43 | $22,669.49 | -100% | -31.2% | -68.6% | |
| Jan 6, 2021 | STOK Stoke Therapeutics, Inc. | COO &Cbo | Sale+OE | 5,732 | $58.96 | $337,985.41 | -46.8% | - | - | |
| Dec 18, 2020 | STOK Stoke Therapeutics, Inc. | COO &Cbo | Sale+OE | 50,000 | $60.00 | $3,000,000.00 | -100% | - | - | |
| Dec 1, 2020 | STOK Stoke Therapeutics, Inc. | COO &Cbo | Sale+OE | 5,700 | $49.84 | $284,079.62 | -59.5% | - | - | |
| Nov 10, 2020 | STOK Stoke Therapeutics, Inc. | COO &Cbo | Sale+OE | 50,000 | $45.00 | $2,250,000.00 | -100% | - | - | |
| Nov 2, 2020 | STOK Stoke Therapeutics, Inc. | COO &Cbo | Sale+OE | 5,700 | $37.21 | $212,109.89 | -69.2% | - | - | |
| Oct 1, 2020 | STOK Stoke Therapeutics, Inc. | COO &Cbo | Sale+OE | 5,700 | $34.54 | $196,900.52 | -71.3% | - | - | |
| Sep 9, 2020 | STOK Stoke Therapeutics, Inc. | COO &Cbo | Sale+OE | 47,919 | $30.00 | $1,437,570.00 | -100% | - | - | |
| Sep 1, 2020 | STOK Stoke Therapeutics, Inc. | COO &Cbo | Sale+OE | 5,700 | $27.74 | $158,112.63 | -89.1% | - | - |